Skip to main content

Closed

KLRS: Kalaris Therapeutics Inc Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

14thpctl

Volume

0.26×avg

Market Cap

65.65MUSD

P/E Ratio

-1.6TTM

Div Yield

-ann

Kalaris Therapeutics Inc

KLRSNASDAQ Global Market·USD·Closed

Kalaris Therapeutics Inc

KLRSNASDAQ·USD·Closed

$3.51

+0.86%

$3.51

+$0.03 (0.86%)

52W Range

14thpctl

Volume

0.26×avg

Mkt Cap

65.65MUSD

P/E

-1.6TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings